OL
TMDX icon

Odyssean LLC’s Transmedics TMDX Stock Holding History

Odyssean LLC’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$851K Buy
12,814
+8,424
+192% +$713K 0.14% 235
2026
Q1 		$436K Buy
+4,390
New +$573K 0.16% 224

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $2.7B AUM 88.53% 1-Year Est. Return

Odyssean LLC's TMDX Position: Q2 2026 in Review

Odyssean LLC increased its Transmedics (TMDX) stake by 192% in Q2 2026, buying an estimated $713K and bringing the position to 12,814 shares worth $851K. The position accounts for 0.14% of the portfolio, ranked #235.

Odyssean LLC first reported a position in TMDX in Q1 2026 and has held it in 2 quarters since. 371 funds tracked by Wall St. Rank hold TMDX as of Q2 2026.

  • Odyssean LLC held 12,814 shares of Transmedics worth $851K as of Q2 2026.
  • Odyssean LLC bought 8,424 Transmedics shares in Q2 2026, an estimated $713K.
  • Transmedics made up 0.14% of Odyssean LLC's portfolio in Q2 2026, its #235 holding.
  • Odyssean LLC first reported a position in Transmedics in Q1 2026 and has held it in 2 quarters since.
  • 371 funds tracked by Wall St. Rank held Transmedics as of Q2 2026.

Based on Odyssean LLC's 13F filing for Q2 2026, filed 14 Aug 2026.